Due to the emerging public health impact of the coronavirus outbreak (COVID-19), and to support the health and well-being of the Company’s partners, employees and shareholders, the Company is moving the location of the meeting with the hope of minimizing interactions amongst those attending the meeting and the employee population at the Company’s headquarters. The Annual Meeting will be held on Thursday, March 19, 2020, at 10:30 a.m., Eastern Time at the Courtyard Marriott Lafayette, located at 150 Fairington Avenue, Lafayette, Indiana 47905. The Company urges shareholders to consider voting and submitting proxies in advance of the Annual Meeting, in lieu of attending the meeting in person.
Dr. Francisco is an accomplished leader in our industry, with a history of success in managing teams and initiatives focused on improving client experiences. Creating Excellent Client Experiences is an Inotiv core value.
CEBU CITY, Philippines — Cebu City Police Office (CCPO) Chief Police Colonel Josefino Ligan, is asking barangay officials here to monitor and create a system in securing their areas, especially those along the coastlines. This, after two individuals were abl…
Barangay health workers in Mambaling, Cebu City are worried about their safety and security as asymptomatic COVID-19 patients confined at the barangay isolation center are allegedly harassing them.
Consider this: from the time they arrive for preseason practice until the end of the season, college athletes are in the same physical space with someone, or something touched by another human being. Think about these areas of a practice facility:
Bioanalytical Systems, Inc. (BASI), operating as Inotiv (the “Company” or “Inotiv”), is pleased to announce the launch of its new website, inotivco.com. The website reinforces the Company’s new brand, “Inotiv,” which symbolizes the union of legacy contract research services with those acquired in the Seventh Wave Laboratories, Smithers Toxicology Services, and Pre-Clinical Research Services acquistions. Over the past year, the Company has worked hard and invested in program management and processes to coordinate teams and services at all of the Company’s sites, moving from a collective of broad responsibilities to more focused teams that are integrated and aligned with key client and internal needs.
Bioanalytical Systems, Inc. (BASI) (“BASi”, the “Company”, “We” or “Our”) doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced the closing and receipt of funds from the SBA Paycheck Protection Program (“PPP”). During the Coronavirus (COVID-19) crisis, the Company is continuing operations. As a company within the “essential critical infrastructure” industry, the Company believes it has a special responsibility to maintain business continuity and a normal work schedule to the greatest extent practicable.
[Nyasa Times] Hitting out at Atupele Muluzi the running mate to President Peter Mutharika in the governing Democratic Progressive Party (DPP) and UDF alliance, for his remarks in which he seemed to suggest that the late Malawi Police Service Superintendent Us…
#mp-video_content__1713760{position: relative;padding-bottom: 56.25%;height: 0 !important;overflow: hidden;width: 100% !important;} #mp-video_content__1713760 .brid, #mp-video_content__1713760 iframe...
[Nairobi News] Kenyan pop artiste David Mathenge, better known by his stage name Nameless shared with his fans about his first date with wife Wahu Kagwi back in the day.
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the addition of William D. Pitchford, BS, MA, as Chief Human Resources Officer, effective as of August 28, 2019. Mr. Pitchford fills an important leadership position, as the Company invests in unifying and strengthening its corporate culture following the acquisition of Seventh Wave Laboratories in July of last year and, more recently, the Smithers Avanza Toxicology Services business unit in May.
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
WEST LAFAYETTE, Ind., Feb. 14, 2020 -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of.
WEST LAFAYETTE, Ind., Dec. 23, 2019 -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) doing business as Inotiv, a leading provider of.
Bioanalytical Systems, Inc. (BASI), operating as Inotiv (the “Company” or “Inotiv”), today announced the appointment of Beth A. Taylor, CPA, as Vice President - Finance and Chief Financial Officer of the Company. Ms. Taylor succeeds Jill C. Blumhoff, who had served as the Company’s Vice President - Finance and Chief Financial Officer since May 2016. Ms. Taylor joins the Company with an extensive background in corporate and operational finance and accounting, including as Vice President of Finance and Chief Accounting Officer for Endocyte, Inc. Ms. Taylor possesses exceptional experience and expertise in business planning, technical accounting, compliance, and investor relations for public companies, and a successful track record of cultivating support and relationships within organizations to achieve goals.
If you own shares in Bioanalytical Systems, Inc. (NASDAQ:BASI) then it's worth thinking about how it contributes to...
Inotiv represents the union of Bioanalytical Systems, Inc.’s (BASi’s), Seventh Wave Laboratories’, and Smithers Avanza Toxicology Services’ in vivo toxicology, pharmacology, drug metabolism, bioanalysis, and pharmacokinetic (PK) solutions, as well as the Company’s expansion into surgical and medical device contract research services with the expected acquisition of the Pre-Clinical Research Services business. The rebrand reflects the Company’s increased scope of services and its resulting position as a top contract research organization (CRO) for drug discovery and development.
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the addition of Stewart B. Jacobson, DVM, DACVP, as Vice President, Pathology, effective October 1, 2019. Dr. Jacobson is an accomplished executive, skilled in strategic leadership, and brings over eighteen years of experience to the Company.
Whilst it may not be a huge deal, we thought it was good to see that the Bioanalytical Systems, Inc. (NASDAQ:BASI...
[Per visionare il trailer clicca sull'immagine in alto] Cast e personaggi Henry Thomas: Elliott Dee Wallace: Mary Robert MacNaughton: Michael Drew Barrymore: Gertie Peter Coyote: Keys Erika...
This article explores the changes that occurred in harvesting technology during the dispersal of the Neolithic in the Mediterranean basin. It does so through technological and use-wear analysis of flaked stone tools from archaeological sites dated between ca.…
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
In connection with the closing, the Company also closed on additional funding, which positions the Company to make future investments in organic growth in the drug metabolism and pharmacokinetics arena. The Company, which recently announced the rebranding of the Company’s contract research services business under the name Inotiv, closed on the PCRS business on December 1, 2019.
WEST LAFAYETTE, Ind., May 14, 2020 -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of.
Generally speaking, investors are inspired to be stock pickers by the potential to find the big winners. You won't get...
Apply Coupon : TOGETHER for 20% discount Free Shipping on 25$+ orders https://wahlpro.com/store/taper-2000-colors-08472-700.html - 28$+ Tax (After coupon) https://wahlpro.com/store/pro-basi ...
Even if it's not a huge purchase, we think it was good to see that Beth Taylor, the CFO & VP of Finance of...
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”), a leading provider of nonclinical and analytical contract research services, today announced that the Company has entered into an agreement to purchase substantially all of the assets of Pre-Clinical Research Services, Inc. (“PCRS”), a premier provider of surgical and medical device contract research services. “We have great respect for the people and services provided by PCRS, and believe the current facilities in Ft. Collins, Colorado, will be an excellent location for future growth,” said Bob Leasure, BASi’s President and Chief Executive Officer.
Wall Street analysts predict these three stocks will continue to outperform the US market Continue reading...